Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 2 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 18 hours agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 2 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
GSK profit drops in first quarter on higher costs
Digital Journal· 2 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 5 hours agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 8 hours agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Superbug Slayer: New Class of Antibiotics Proves Potent Against Multi-Drug Resistant Bacteria
SciTechDaily· 3 days agoA new class of antibiotics capable of combating multi-drug resistant bacteria and treating bloodstream infections in mice has been unveiled by Uppsala University scientists. Scientists at Uppsala ...
Suddenly, Chinese Spies Seem to Be Popping Up All Over Europe
The New York Times via Yahoo News· 6 days agoOne of the men, a young Briton known for his hawkish views on China, worked as an aide to a...
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
The Wall Street Journal· 6 days agoHis lab there found that resveratrol appeared to prolong the lifespan of mice. Sinclair was one of...
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
ABC News· 3 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...